These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6498086)

  • 1. Cellular uptake of clindamycin and lincomycin.
    Easmon CS; Crane JP
    Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
    Barcs I
    J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
    Jakubicz P; Dzierzanowska D
    Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
    [No Abstract]   [Full Text] [Related]  

  • 5. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
    Bassler M; Just HM; Richter A; Zeller H; Daschner F
    Infection; 1984; 12(4):280-5. PubMed ID: 6490174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of antibiotics in chronic granulomatous disease leukocytes.
    Jacobs RF; Wilson CB
    Pediatr Res; 1983 Nov; 17(11):916-9. PubMed ID: 6646904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.
    Leclercq R; Carlier C; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1985 Sep; 28(3):421-4. PubMed ID: 3907492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
    Devriese LA
    Ann Microbiol (Paris); 1980; 131B(3):261-6. PubMed ID: 7469255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
    Cialdella JI; Vavra JJ; Marshall VP
    J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lincomycin, clindamycin and their applications.
    Spízek J; Rezanka T
    Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phagocyte membrane stimulation on antibiotic uptake and intracellular bactericidal activity.
    Steinberg TH; Hand WL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):660-2. PubMed ID: 3606071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cloxacillin on staphylococci phagocytosed by bovine neutrophils.
    Craven N; Anderson JC
    Res Vet Sci; 1980 Jul; 29(1):57-62. PubMed ID: 7455355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of several antibiotics against intracellular S. aureus in chronic granulomatous disease.
    Zimmerli W; Lew PD; Suter S; Wyss M; Waldvogel FA
    Helv Paediatr Acta; 1983 Mar; 38(1):51-61. PubMed ID: 6862995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between antibiotics and human neutrophils in the killing of staphylococci.
    Root RK; Isturiz R; Molavi A; Metcalf JA; Malech HL
    J Clin Invest; 1981 Jan; 67(1):247-59. PubMed ID: 7451652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical microbiology of lincomycin antibiotics].
    Modde H
    Fortschr Med; 1973 May; 91(15):677-82. PubMed ID: 4145081
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a method for measurement of intracellular killing of Staphylococcus aureus in human neutrophil granulocytes.
    Nielsen SL; Black FT; Storgaard M; Obel N
    APMIS; 1995 Jun; 103(6):460-8. PubMed ID: 7546649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
    Sula L; Sulová J
    Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.